Recombinant human erythropoietin therapy in critically ill patients: a dose-response study [ISRCTN48523317]

INTRODUCTION: The aim of this study was to assess the efficacy of two dosing schedules of recombinant human erythropoietin (rHuEPO) in increasing haematocrit (Hct) and haemoglobin (Hb) and reducing exposure to allogeneic red blood cell (RBC) transfusion in critically ill patients. METHOD: This was a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Georgopoulos, Dimitris, Matamis, Dimitris, Routsi, Christina, Michalopoulos, Argiris, Maggina, Nina, Dimopoulos, George, Zakynthinos, Epaminondas, Nakos, George, Thomopoulos, George, Mandragos, Kostas, Maniatis, Alice
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2005
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1297615/
https://ncbi.nlm.nih.gov/pubmed/16277712
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/cc3786
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados